Parkin Regulates Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury by Targeting Cyclophilin-D

Area of Science:

• Cardiovascular Biology
• Cell Death Mechanisms
• Mitochondrial Biology

Background:

• Cardiomyocyte death, particularly necrosis, is central to cardiac disorders like myocardial infarction and ischemia/reperfusion (I/R) injury.
• While pathways involving death receptors, RIP kinases, and cyclophilin-D (CypD) are implicated, the mitochondrial permeability transition pore (mPTP)-CypD-dependent necroptosis mechanism in the heart remains unclear.
• Parkin, an E3 ubiquitin ligase known for mitophagy, has an undefined role in cardiac necrosis and I/R injury.

Purpose of the Study:

• To investigate the role of Parkin in regulating myocardial necrosis and I/R injury.
• To elucidate the underlying molecular mechanisms by which Parkin influences cardiac cell death pathways.
• To determine if Parkin's function in necrosis is linked to its known role in mitophagy.

Main Methods:

• Investigated Parkin's effect on cardiomyocyte necrosis under oxidative stress.
• Examined Parkin's interaction with cyclophilin-D (CypD) and the mitochondrial permeability transition pore (mPTP).
• Assessed Parkin's impact on myocardial I/R injury and cardiac function in vivo.

Main Results:

• Parkin was found to inhibit necrosis and reduce myocardial I/R injury, improving cardiac function.
• Parkin suppressed mPTP opening by catalyzing the ubiquitination of CypD, a mechanism distinct from Parkin-mediated mitophagy.
• Parkin's protective effects against necrosis were independent of its mitophagy function.

Conclusions:

• Parkin plays a novel role in suppressing myocardial necrosis by targeting the mPTP-CypD pathway.
• Parkin's ubiquitination of CypD inhibits mPTP opening, thereby protecting cardiomyocytes from death and reducing I/R injury.
• This study reveals Parkin as a key regulator of a novel myocardial necrotic pathway, presenting potential therapeutic targets for cardiac disorders.